期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

B7-H1及其受体PD-1在膀胱癌患者外周血免疫细胞中的表达及其临床意义 被引量：3

Expressions and significance of B7-H1 and PD-1 in peripheral blood immune cells from patients with bladder cancer
原文传递
导出
摘要 目的:研究膀胱癌患者外周血中树突状细胞(dendritic cells,DCs)表面B7-H1和CD8+T淋巴细胞表面PD-1的表达情况及其临床意义。方法:分离30例膀胱癌患者外周血单个核细胞(peripheral blood mononu-clear cell,PBMC),联合培养后采用流式细胞术检测DCs表面B7-H1及CD8+T细胞表面PD-1的表达情况。结果:膀胱癌患者外周血DCs表面B7-H1表达水平及CD8+T细胞表面PD-1表达水平均明显高于正常人,差异具有显著统计学意义(P<0.01),并且二者的表达水平随着病理分级和临床分期的增加均升高,差异有统计学意义(P<0.05)。结论:在膀胱癌发生发展过程中存在着DCs表面B7-H1和CD8+T细胞表面PD-1分子表达的上调,B7-H1/PD-1信号通路可能在T细胞免疫应答的初始阶段亦参与了膀胱癌免疫逃逸的发生。 Objective：To study the expressions and the clinical significance of BT-H1 on dendritic cell and PD-1 on CD8＋T lymphocytes cells in peripheral blood from patients with bladder cancer. Methods： Peripheral blood mononuclear cell were disparted from 30 bladder cancer patients and 10 healthy controls by density gradient centrifugation and then co-cultured. The expressions of BT-H1 on dendritic cells （DCs） and PD-1 on CD8 ＋T lymphocytes were analyzed by flow cytometry. Results： Expressions of BT-H1 on dendritic cells and PD-1 on CD8 ＋T lymphocytes in bladder cancer were higher than healthy controls （P〈0.01）. And the expressions were strongly associated with the pathological grade and clinical stage of bladder cancer （P〈0.05）. Conclusions：The upregulation of BT-H1 on DCs and PD-1 on CD8 ＋T lymphocytes were strongly associated with neoplastic progression of bladder cancer. BT-H1/PD-1 signal passway may also play an important role in immune escape of bladder cancer during initial phase of T cell immune response.
作者 纪传彪 王永华 于芹超 刘静 崔杰 公欣海
机构地区 青岛大学医学院附属医院泌尿外科 青岛大学医学院附属医院儿科
出处 《临床泌尿外科杂志》 2013年第3期196-198,共3页 Journal of Clinical Urology
基金 国家自然科学基金青年科学基金项目(编号81101932)
关键词 膀胱肿瘤 B7-H1 PD-1 树突状细胞 CD8+T淋巴细胞 免疫逃逸 bladder cancer BT-H1 PD-1 dendritic cells CD8＋t lymphocytes immune escape
分类号 R737.14 [医药卫生—肿瘤]
  • 相关文献

参考文献11

  • 1Chemnitz J M, Parry R V, Nichols K E, et al. SHP-1 and SHP-2 associate with immunoreceptor ryrosine- based switch motif of programmed death-1 upon prima- ry T cell stimulation,but only receptor ligation prevents Tcellactivation[J]. J Immunol, 2004, 173(2):945- 954.
  • 2Fife B T, Guleria I, Gubbels Bupp M, et al. Insulin-in- duced remission in new-onset NOD mice is maintained by the PD-1-PD-LI[J]. J Exp Med, 2006, 203..2737- 2747.
  • 3Tsushima F, Yao S, Shin T, et al. Interaction between B7-H1 and PD-1 determines initiation and reversal of T- cell anergy[J]. Blood, 2007, 110:180-185.
  • 4Gajewski T F, Meng Y, Harlin H, et al. Immune sup- pression in the tumor microenvironment[J]. J Immu- nother, 2006, 29(3):233-240.
  • 5Dong H, Strome S E, Salomao D R, et al. Tumor-as- sociated B7-H1 promotes T-cell apoptosis; a potential mechanism of immune evasion[J]. Nat Med, 2002, 8 (8) :793-800.
  • 6Keir M E, Butte M J, Ereeman G J, et al. PD-1 and its ligands in tolerance and immunity[J]. Annu Rev Immu- nol, 2008, 26..677-704.
  • 7Freeman G J, Long A J, Iwai Y, et al. Engagement of the PD-1 immuninhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte acti vation[J].J Exp Med, 2000, 192(7):1027-1034.
  • 8Seo S K,Seo H M, Jeong H Y, et al. Co-inhibitory role of t cell associated B7-H1 and B7 DC in the T-cell im- mune response[J]. Immunol Lett, 2006, 1 02(2):222 -228.
  • 9Hinrichs C S, Spolski R, Paulos C M, et al. IL-2 and IL-24 confer-opposing differentiation programs to CD8 + T cells for sdoptive immunotherapy[J]. Blood, 2008, 111(11) :5326-5333.
  • 10王永华,庄乾元.共刺激分子B7-H1和FasL在膀胱移行细胞癌免疫逃逸中的机制研究及临床意义[J].临床泌尿外科杂志,2008,23(9):684-686. 被引量：1

二级参考文献9

  • 1Dong H, Strome S E, Salomao D R, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion [J].Nat Med, 2002, 8 (8): 793-800
  • 2Hahne M, Rimold D, Schroter M, et al. Melanoma ceils expression of Fas (AP0-1/CD95) ligand: implications for tumor immune escape[J]. Science, 1996, 274:1363-1366.
  • 3Dong H, Zhu G, Tamada K, et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion[J]. Nat Med, 1999, 5(12): 1365-1369.
  • 4Brown J A, Dorfman D M, Ma F R, et al. Blockade of programmed death 1 ligands on dendritic cells enhanced T cell activation and cytokine production [J].J Immunol, 2003, 170(3): 1257-1266.
  • 5Strome S E, Dong H, Tamura H, et al. B7-H1 blockade augments adoptive T-cell immunotherapy for squa mous cell carcinoma[J]. Cancer Res, 2003, 63(19) 6501-6505.
  • 6Thompson R H, Gillett M D, Cheville J C, et al. Costimulatory B7-Hlin renal cell carcinoma patients.. Indicator of tumor aggressiveness and potential therapeutic target[J]. Proc Natl Acad Sci USA, 2004, 101(49): 17174-17179.
  • 7Inman B A, Sebo T J, Frigola X, et al. PD-L1 (BTH1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression[J]. Cancer, 2007, 109(8) : 1499 -1505.
  • 8Suda T, Takahashi T, Golstein P, et al. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family [J]. Cell, 1993, 75:1169-1178.
  • 9Cui H, Matsui K, Omura S, et al. Regulation of T-cell deathgenes:selective inhibition of FasL but not Fas mediated function [J].Cellular Immunol, 1996, 167 : 276.

同被引文献10

引证文献3

二级引证文献4

临床泌尿外科杂志
2013年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部